What is the global market size of CRISPR Technology Market?

CRISPR Technology Market size was valued at USD 2.54 billion in 2021 and is poised to grow from USD 2.94 billion in 2022 to USD 10.84 billion by 2030, growing at a CAGR of 15.6% during the forecast period (2023-2030).

What is the key driver of Global CRISPR Technology Market?

Governments from all around the world have significantly increased their financing and investment in CRISPR technology. As a result, the field now offers a favourable environment for research and development, enabling ground-breaking discoveries and advancing the market.

What is the key market trend for Global CRISPR Technology Market?

One key market trend in the CRISPR technology market is the increasing adoption of CRISPR in drug discovery and development. Pharmaceutical and biotechnology companies are recognizing the potential of CRISPR technology to accelerate the drug discovery process, improve target identification and validation, and enhance preclinical and clinical studies. CRISPR-based screening platforms allow researchers to identify and validate potential drug targets more efficiently, leading to the development of more effective therapies. Additionally, CRISPR enables the creation of disease models and organoids for studying disease mechanisms and evaluating drug candidates. Overall, the key market trends in the CRISPR technology market include the adoption of CRISPR in drug discovery, its applications in agriculture and food production, the development of CRISPR-based diagnostics, and the increasing emphasis on ethical and regulatory considerations. These trends highlight the expanding potential and impact of CRISPR technology across various industries.

Which region accounted for the largest share in CRISPR Technology Market?

North America dominated the global CRISPR Technology market. The region has a well-established biotechnology and pharmaceutical industry, significant research funding, and a favorable regulatory environment. The United States, in particular, is a key player in the market, with numerous companies actively involved in CRISPR research, development, and commercialization. North America benefits from a strong ecosystem of academic institutions, research organizations, and industry collaborations, fostering innovation and driving market growth.

Top CRISPR Technology Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the CRISPR Technology Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading CRISPR Technology industry players.

CRISPR Technology Market Competitive Landscape

The competitive landscape in the CRISPR technology market is characterized by the presence of several key players that are actively engaged in research, development, and commercialization of CRISPR-based products and services. These companies compete in various segments of the market, including therapeutics, diagnostics, agriculture, and research tools. The competitive landscape in the CRISPR technology market is characterized by intense research and development activities, strategic collaborations, and a focus on commercialization. As the market continues to grow, competition is expected to further intensify, driving innovation and advancements in CRISPR-based products and services.

CRISPR Technology Market Top Player’s Company Profiles

Editas Medicine, Inc. (US)

CRISPR Therapeutics (Switzerland)

Intellia Therapeutics (US)

Caribou Biosciences, Inc. (US)

Cellectis (France)

Precision Biosciences (US)

Sangamo Therapeutics (US)

Lonza Group Ltd. (Switzerland)

Merck KGaA (Germany)

Horizon Discovery Group plc (UK)

Thermo Fisher Scientific (US)

Integrated DNA Technologies, Inc. (US)

GenScript Biotech Corporation (China)

Synthego Corporation (US)

New England Biolabs (US)

OriGene Technologies, Inc. (US)

Agilent Technologies, Inc. (US)

Takara Bio Inc. (Japan)

Addgene (US)

Eurofins Scientific (Luxembourg)

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global CRISPR Technology Market size was valued at USD 3.50 Billion in 2024 and is poised to grow from USD 4.08 Billion in 2025 to USD 13.84 Billion by 2033, growing at a CAGR of 16.5% during the forecast period (2026–2033).

Key vendors in the CRISPR Technology Market include CRISPR Therapeutics AG, Editas Medicine Inc., Intellia Therapeutics Inc., Beam Therapeutics Inc., Caribou Biosciences Inc., Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, GenScript Biotech Corporation, and Integrated DNA Technologies Inc.. These companies focus on CRISPR-based gene-editing platforms, therapeutic development, genome engineering tools, and research solutions for biotechnology, healthcare, and agricultural applications.

The key driver of the CRISPR Technology Market is the increasing demand for precise and efficient gene-editing solutions in healthcare, biotechnology, and agricultural applications. Rising prevalence of genetic disorders, growing investments in genomic research, and expanding development of gene therapies and precision medicine approaches are significantly driving market growth globally.

The key market trend in the CRISPR Technology Market is the rapid advancement of CRISPR-based therapeutics and next-generation gene-editing platforms. Increasing focus on precision medicine, in vivo gene editing, base editing, and prime editing technologies, along with growing clinical research for genetic and rare diseases, is driving innovation and expanding the application scope of CRISPR technology globally.

North America accounted for the largest share in the CRISPR Technology Market due to substantial investments in biotechnology and genomic research, strong funding for gene-editing initiatives, and the presence of leading CRISPR technology companies. Advanced research infrastructure, increasing clinical trials, and growing adoption of CRISPR-based applications in healthcare and life sciences further support regional market dominance.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Luca Giovannini, Marketing Innovation Senior Manager, Trelleborg.

Top CRISPR Technology Companies

CRISPR Technology Market Competitive Landscape

FAQs

What is the global market size of CRISPR Technology Market?

Who are the key vendors in the CRISPR Technology Market?

What is the key driver of CRISPR Technology Market?

What is the key market trend for CRISPR Technology Market?

Which region accounted for the largest share in CRISPR Technology Market?

Request Free Customization